Research summaries for everyoneNot medical advice
DSIP research reference vial, Elevated Pharma

Research reference · Cognition & Sleep

DSIP

Delta sleep-inducing peptide (DSIP, emideltide) is a nonapeptide isolated in the 1970s. Small human sleep studies from the 1980s and 1990s reported mixed results.

Published by Elevated Pharma ·

Cognition & SleepLimited human literature

Identity

What is DSIP?

A nonapeptide, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu.

Research context

What has DSIP been studied for?

Early isolation work defined the sequence; small clinical studies in insomnia found weak or inconsistent effects.

Evidence boundary

What does the research not show?

The limited, mixed human literature does not establish benefit or safety.

U.S. status · November 7, 2026

Is DSIP FDA-approved?

FDA’s compounding advisory committee voted 7–6 (one abstention) against adding emideltide (DSIP) to the 503A bulks list on July 24, 2026, the only one of seven peptides it turned down. It is not covered by the October 2026 HHS interim policy.

Research updates

What’s new

Dated developments for DSIP, newest first. See all research updates.

  1. FDA advisory committee votes

    FDA’s Pharmacy Compounding Advisory Committee voted on seven peptides over July 23–24, recommending six and declining emideltide (DSIP).

    Read the source

Key studies

The main DSIP research

Selected from PubMed: human trials first, then reviews, then foundational laboratory work. Each finding applies to the material and setting studied.

Search all 408 PubMed records for DSIP · Counts and selections checked November 7, 2026.

Reference identifiers

DSIP identity data

Database identity describes the reference substance, not any specific material or lot.

Primary name
DSIP
Also indexed as
Delta sleep-inducing peptide / DSIP / Emideltide
Sequence
Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
Molecular formula
C35H48N10O15
Molecular mass
848.8 g/mol
PubChem CID
68816

Official & primary sources

Regulatory and database records

Citation does not imply an Elevated Pharma partnership or endorsement.